These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10734825)

  • 21. Secretin treatment for autism.
    Herlihy WC
    N Engl J Med; 2000 Apr; 342(16):1217; author reply 1218. PubMed ID: 10777378
    [No Abstract]   [Full Text] [Related]  

  • 22. Secretin treatment for autism.
    Said SI; Bodanszky M
    N Engl J Med; 2000 Apr; 342(16):1217-8. PubMed ID: 10777379
    [No Abstract]   [Full Text] [Related]  

  • 23. Secretin as a treatment for autism: a review of the evidence.
    Esch BE; Carr JE
    J Autism Dev Disord; 2004 Oct; 34(5):543-56. PubMed ID: 15628608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretin treatment for autism.
    Horvath K
    N Engl J Med; 2000 Apr; 342(16):1216; author reply 1218. PubMed ID: 10777376
    [No Abstract]   [Full Text] [Related]  

  • 25. Development. Desperate parents spark search for new treatment.
    Stokstad E
    Science; 2001 Oct; 294(5540):37. PubMed ID: 11588235
    [No Abstract]   [Full Text] [Related]  

  • 26. Comments on "Secretin and autism: a two-part clinical investigation" by M.G. Chez et al.
    Rimland B
    J Autism Dev Disord; 2000 Apr; 30(2):95; discussion 97-8. PubMed ID: 10832773
    [No Abstract]   [Full Text] [Related]  

  • 27. Secretin in autism--a parent's perspective.
    Klaeger D; McDougle CJ
    J Autism Dev Disord; 2000 Feb; 30(1):72-3. PubMed ID: 10819124
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of benefit of intravenous synthetic human secretin in the treatment of autism.
    Molloy CA; Manning-Courtney P; Swayne S; Bean J; Brown JM; Murray DS; Kinsman AM; Brasington M; Ulrich CD
    J Autism Dev Disord; 2002 Dec; 32(6):545-51. PubMed ID: 12553591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood autism: a circuit syndrome?
    Lee DA; Lopez-Alberola R; Bhattacharjee M
    Neurologist; 2003 Mar; 9(2):99-109. PubMed ID: 12808372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regarding secretin for treating autistic disorder.
    Aman MG; Armstrong SA
    J Autism Dev Disord; 2000 Feb; 30(1):71-2. PubMed ID: 10819123
    [No Abstract]   [Full Text] [Related]  

  • 31. Secretin treatment for autistic disorder: a critical analysis.
    Patel NC; Yeh JY; Shepherd MD; Crismon ML
    Pharmacotherapy; 2002 Jul; 22(7):905-14. PubMed ID: 12126223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of secretin for the treatment of autism].
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Kuroda Y
    No To Hattatsu; 2004 Jul; 36(4):289-95. PubMed ID: 15272612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homeopathic Secretin in autism: a clinical pilot study.
    Robinson TW
    Br Homeopath J; 2001 Apr; 90(2):86-91. PubMed ID: 11341462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What to measure in autism drug trials.
    Roseman B; Schneider E; Crimmins D; Bostwick H; Visintainer P; Jaskow PA; Accardo P
    J Autism Dev Disord; 2001 Jun; 31(3):361-2. PubMed ID: 11518490
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of secretin on children with autism: a randomized controlled trial.
    Dunn-Geier J; Ho HH; Auersperg E; Doyle D; Eaves L; Matsuba C; Orrbine E; Pham B; Whiting S
    Dev Med Child Neurol; 2000 Dec; 42(12):796-802. PubMed ID: 11132252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Secretin and autism: a two-part clinical investigation.
    Clark CE
    J Autism Dev Disord; 2001 Apr; 31(2):248-9. PubMed ID: 11450825
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.
    Carey T; Ratliff-Schaub K; Funk J; Weinle C; Myers M; Jenks J
    J Autism Dev Disord; 2002 Jun; 32(3):161-7. PubMed ID: 12108617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel treatments for autistic spectrum disorders.
    Levy SE; Hyman SL
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
    Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
    Unis AS; Munson JA; Rogers SJ; Goldson E; Osterling J; Gabriels R; Abbott RD; Dawson G
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1315-21. PubMed ID: 12410073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.